Alveo Technologies

Alveo is leading the transformation of the consumer health tech market by developing a low-cost, easy- to-use, at-home diagnostic platform that has the potential to change the way infectious diseases are detected & managed.The company’s be.well testing system is designed to give individuals access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases.With an initial focus on acute respiratory infections including COVID-19, Flu A/B & RSV, Alveo’s agile and dynamic diagnostic platform could be adapted to detect a wide range of diseases that threaten public health.We believe affordable access to real-time, at-home results will transform the way individuals, healthcare providers and public health professionals identify and manage disease outbreaks.With be.well™, we will Know Sooner, Act Faster and make better-informed decisions regarding personalized intervention options that benefit individuals and the entire population.